Dr. Omar Hamada warned that failed Tennessee legislation to ban mRNA products and research would have harmed medical innovation and threatened the state’s position as a national healthcare leader.
During an interview with The Tennessee Star’s CEO and Editor-in-Chief Michael Patrick Leahy, Hamada criticized legislative efforts such as the proposed Tennessee mRNA Pharmaceutical Sovereignty and Safety Act, sponsored during the latest legislative session by State Senator Janice Bowling (R-Tullahoma), who also filed the mRNA Bioweapons Prohibition Act.
The bills would have prohibited the administration, possession, manufacture, or distribution of mRNA-based products in Tennessee.
When asked about legislation targeting mRNA technology during last Friday’s edition of The Michael Patrick Leahy Show, Hamada’s initial response was, “Bad idea.”
He argued that many opponents of mRNA technology misunderstand what messenger RNA actually is.
Hamada explained mRNA as being “something that is in existence in our cells.”
“It’s messenger RNA. There are different kinds of RNA. There’s ribosomal RNA, there’s messenger RNA, there’s transfer RNA, and it’s basically how proteins get made,” the doctor said.
He described messenger RNA as a fundamental biological process necessary for human life.
“Messenger RNA is essential. It’s not something that we can take out of our cells. We’d die. It’s like saying we’re against blood, we’re gonna take all the blood out of us. We can’t,” he said.
Hamada acknowledged concerns surrounding the COVID-era mRNA shots, which he distinguished from the broader field of mRNA research.
“Unfortunately, this was fast-tracked with the COVID shot during the COVID pandemic, and everyone all of a sudden, that’s all they knew about it, and they just turned against it, and it’s ‘Yo, it’s bad,'” Hamada said.
He further argued that the COVID-era application of mRNA technology produced harmful effects.
“This was using mRNA technology to make a certain protein, the spike protein, in the cell to then create immunity against it. But what that did, it caused clotting diseases, it caused an increase in certain types of cancers and all sorts of stuff. It was a bad deal,” Hamada said.
However, Hamada maintained that the underlying technology itself remains valuable and has significant medical potential.
“But mRNA technology itself is valuable and necessary. Even way before COVID happened, we’ve been looking at mRNA technology for decades, and we are getting to the point now that we can utilize it to cure various diseases in a good way, like reverse cancer, like prevent cancer in ways that aren’t dangerous like the COVID shot was,” he said.
Because of those potential medical applications, Hamada said efforts to broadly prohibit mRNA technology would be harmful.
“So to come out with legislation that tries to kill this is not only dangerous, it’s stupid,” he said.
The physician also emphasized Tennessee’s role as a major healthcare and research hub, noting the state’s concentration of hospitals, medical schools, and healthcare companies.
“We are a powerhouse in Tennessee,” Hamada said, citing institutions including HCA, Vanderbilt, Ascension, St. Jude Children’s Research Hospital, Le Bonheur Children’s Hospital, Campbell Clinic Orthopedics, and the Semmes Murphey Clinic.
Hamada also highlighted Memphis’ healthcare sector.
“Memphis is a diamond in terms of healthcare,” he said. “Memphis is a gem…Tennessee is a powerhouse when it comes to healthcare. Nashville’s great when it comes to not just healthcare, but technology and business and innovation. Memphis is a clinical gem.”
“To have legislation that takes us back to the Dark Ages – not a good idea,” Hamada said.
Tune in now to The Michael Patrick Leahy Show – your AMERICA FIRST news talk!
– Watch LIVE here on X
– Watch LIVE on YouTube / Rumble / Roku / AppleTV
– Listen on Spotify
– Listen on WENO AM760 in Nashville
– Read more at @TheTNStar https://t.co/honZxxcGUU— Michael Patrick Leahy (@michaelpleahy) June 5, 2026
– – –
Kaitlin Housler is a reporter at The Tennessee Star and The Star News Network.
